Evaluation and Comparison of Anticonvulsant Activity of Telmisartan and Olmesartan in Experimentally Induced Animal Models of Epilepsy

Evaluation and Comparison of Anticonvulsant Activity of Telmisartan and Olmesartan in Experimentally Induced Animal Models of Epilepsy

Background : Epilepsy is one common neurological disorder requiring newer targets and newer drugs for its efficient management. In the recent days brain renin angiotensin system has gained immense importance because of its involvement in seizure regulation. Objective : To evaluate and compare antiep...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical and diagnostic research 2014-10, Vol.8 (10), p.HC08-HC11
Hauptverfasser: V H, Pushpa, Shetty K, Padmaja, R N, Suresha, M K, Jayanthi, V, Ashwini, P S, Vaibhavi
Format: Artikel
Sprache:eng
Schlagworte:
Pharmacology Section
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page HC11
container_issue 10
container_start_page HC08
container_title Journal of clinical and diagnostic research
container_volume 8
creator V H, Pushpa
Shetty K, Padmaja
R N, Suresha
M K, Jayanthi
V, Ashwini
P S, Vaibhavi
description Background : Epilepsy is one common neurological disorder requiring newer targets and newer drugs for its efficient management. In the recent days brain renin angiotensin system has gained immense importance because of its involvement in seizure regulation. Objective : To evaluate and compare antiepileptic activity of different doses olmesartan and telmisartan on MES and PTZ induced seizure models. Materials and Methods : Swiss albino mice weighing around 25-30g of either sex were divided into 6 groups: Control ( Distilled Water- 10ml/kg), Standard – Sodium valproate (40mg/kg), O1 – Olmesartan (2.5mg/kg), O2 – Olmesartan (5mg/kg), T1 - Telmisartan (5mg/kg), T2 – Telmisartan (10mg/kg). After 1hour of administration of control , test and standard drugs (orally), convulsions were induced by administering PTZ (70mg/kg – i.p.) in PTZ model. Seizure latency was the parameter recorded. In MES model, suppression of tonic hind limb extension was taken as measure of efficacy. Result : The results were analysed by one-way-ANOVA followed by Bonferroni’s multiple comparison test. In MES test, dose dependently olmesartan and telmisartan significantly reduced the duration of tonic hindlimb extension in comparison to control (p
doi_str_mv 10.7860/JCDR/2014/9455.5061
format Article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4253186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_4253186</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_42531863</originalsourceid><addsrcrecordid>eNqlzMtKxDAYBeAgilMvT-AmL9BpmrZpuxGGWlFBBJnF7Mpvm9FfcilNWuwL-Nx2cDauXR0Oh_MRchOzdV4IFj1Vd68RZ3EalWmWrTMm4hMSsDJPwpyVu1MScJ6WYV7w3YpcOPfJmBAiEedkxbM0LxJRBOS7nkCN4NEaCqajldU9DOiWavd0Yzy21kyjcmA83bQeJ_TzYdpKpdHB4OH3-KK0PFY0tP7q5YBaGg9KzfTRdGMru8VDDYo-204qd1DqHpXs3XxFzvagnLw-5iW5va-31UPYj29adu0CDaCafjFhmBsL2PxdDH4073ZqUp4lcSGSfwM_yldz-Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Evaluation and Comparison of Anticonvulsant Activity of Telmisartan and Olmesartan in Experimentally Induced Animal Models of Epilepsy</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>V H, Pushpa ; Shetty K, Padmaja ; R N, Suresha ; M K, Jayanthi ; V, Ashwini ; P S, Vaibhavi</creator><creatorcontrib>V H, Pushpa ; Shetty K, Padmaja ; R N, Suresha ; M K, Jayanthi ; V, Ashwini ; P S, Vaibhavi</creatorcontrib><description>Background : Epilepsy is one common neurological disorder requiring newer targets and newer drugs for its efficient management. In the recent days brain renin angiotensin system has gained immense importance because of its involvement in seizure regulation. Objective : To evaluate and compare antiepileptic activity of different doses olmesartan and telmisartan on MES and PTZ induced seizure models. Materials and Methods : Swiss albino mice weighing around 25-30g of either sex were divided into 6 groups: Control ( Distilled Water- 10ml/kg), Standard – Sodium valproate (40mg/kg), O1 – Olmesartan (2.5mg/kg), O2 – Olmesartan (5mg/kg), T1 - Telmisartan (5mg/kg), T2 – Telmisartan (10mg/kg). After 1hour of administration of control , test and standard drugs (orally), convulsions were induced by administering PTZ (70mg/kg – i.p.) in PTZ model. Seizure latency was the parameter recorded. In MES model, suppression of tonic hind limb extension was taken as measure of efficacy. Result : The results were analysed by one-way-ANOVA followed by Bonferroni’s multiple comparison test. In MES test, dose dependently olmesartan and telmisartan significantly reduced the duration of tonic hindlimb extension in comparison to control (p&lt;0.05). T2 – 9 + 0.89secs significantly reduced the tonic hind limb extension compared to other test groups (p&lt;0.05). The percentage inhibition of seizure was T2-44.3%, O2-28.2%, T1-17.5%, O1- 12.3% respectively. In PTZ test, dose dependently olmesartan and telmisartan produced significant increase in seizure latency (p&lt;0.05). T2 - 206.6+9.83secs significantly increased seizure latency compared to other test groups (p&lt;0.05). Percentage protection from seizure is T2-52.6%, O2- 45.13%, T1- 37.5%, O1- 38.4% respectively. Conclusion : AT1 receptor antagonist, telmisartan and olmesartan in a dose dependent manner showed increase in antiepileptic activity. Temisartan at higher dose produced significant antiepileptic activity in comparison to olmesartan.</description><identifier>ISSN: 2249-782X</identifier><identifier>EISSN: 0973-709X</identifier><identifier>DOI: 10.7860/JCDR/2014/9455.5061</identifier><identifier>PMID: 25478368</identifier><identifier>PMID: 25121000</identifier><language>eng</language><publisher>Delhi, India: JCDR Research and Publications (P) Limited</publisher><subject>Pharmacology Section</subject><ispartof>Journal of clinical and diagnostic research, 2014-10, Vol.8 (10), p.HC08-HC11</ispartof><rights>2014 Journal of Clinical and Diagnostic Research 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253186/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253186/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,725,778,782,862,883,27907,27908,53774,53776</link.rule.ids></links><search><creatorcontrib>V H, Pushpa</creatorcontrib><creatorcontrib>Shetty K, Padmaja</creatorcontrib><creatorcontrib>R N, Suresha</creatorcontrib><creatorcontrib>M K, Jayanthi</creatorcontrib><creatorcontrib>V, Ashwini</creatorcontrib><creatorcontrib>P S, Vaibhavi</creatorcontrib><title>Evaluation and Comparison of Anticonvulsant Activity of Telmisartan and Olmesartan in Experimentally Induced Animal Models of Epilepsy</title><title>Journal of clinical and diagnostic research</title><description>Background : Epilepsy is one common neurological disorder requiring newer targets and newer drugs for its efficient management. In the recent days brain renin angiotensin system has gained immense importance because of its involvement in seizure regulation. Objective : To evaluate and compare antiepileptic activity of different doses olmesartan and telmisartan on MES and PTZ induced seizure models. Materials and Methods : Swiss albino mice weighing around 25-30g of either sex were divided into 6 groups: Control ( Distilled Water- 10ml/kg), Standard – Sodium valproate (40mg/kg), O1 – Olmesartan (2.5mg/kg), O2 – Olmesartan (5mg/kg), T1 - Telmisartan (5mg/kg), T2 – Telmisartan (10mg/kg). After 1hour of administration of control , test and standard drugs (orally), convulsions were induced by administering PTZ (70mg/kg – i.p.) in PTZ model. Seizure latency was the parameter recorded. In MES model, suppression of tonic hind limb extension was taken as measure of efficacy. Result : The results were analysed by one-way-ANOVA followed by Bonferroni’s multiple comparison test. In MES test, dose dependently olmesartan and telmisartan significantly reduced the duration of tonic hindlimb extension in comparison to control (p&lt;0.05). T2 – 9 + 0.89secs significantly reduced the tonic hind limb extension compared to other test groups (p&lt;0.05). The percentage inhibition of seizure was T2-44.3%, O2-28.2%, T1-17.5%, O1- 12.3% respectively. In PTZ test, dose dependently olmesartan and telmisartan produced significant increase in seizure latency (p&lt;0.05). T2 - 206.6+9.83secs significantly increased seizure latency compared to other test groups (p&lt;0.05). Percentage protection from seizure is T2-52.6%, O2- 45.13%, T1- 37.5%, O1- 38.4% respectively. Conclusion : AT1 receptor antagonist, telmisartan and olmesartan in a dose dependent manner showed increase in antiepileptic activity. Temisartan at higher dose produced significant antiepileptic activity in comparison to olmesartan.</description><subject>Pharmacology Section</subject><issn>2249-782X</issn><issn>0973-709X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqlzMtKxDAYBeAgilMvT-AmL9BpmrZpuxGGWlFBBJnF7Mpvm9FfcilNWuwL-Nx2cDauXR0Oh_MRchOzdV4IFj1Vd68RZ3EalWmWrTMm4hMSsDJPwpyVu1MScJ6WYV7w3YpcOPfJmBAiEedkxbM0LxJRBOS7nkCN4NEaCqajldU9DOiWavd0Yzy21kyjcmA83bQeJ_TzYdpKpdHB4OH3-KK0PFY0tP7q5YBaGg9KzfTRdGMru8VDDYo-204qd1DqHpXs3XxFzvagnLw-5iW5va-31UPYj29adu0CDaCafjFhmBsL2PxdDH4073ZqUp4lcSGSfwM_yldz-Q</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>V H, Pushpa</creator><creator>Shetty K, Padmaja</creator><creator>R N, Suresha</creator><creator>M K, Jayanthi</creator><creator>V, Ashwini</creator><creator>P S, Vaibhavi</creator><general>JCDR Research and Publications (P) Limited</general><scope>5PM</scope></search><sort><creationdate>20141001</creationdate><title>Evaluation and Comparison of Anticonvulsant Activity of Telmisartan and Olmesartan in Experimentally Induced Animal Models of Epilepsy</title><author>V H, Pushpa ; Shetty K, Padmaja ; R N, Suresha ; M K, Jayanthi ; V, Ashwini ; P S, Vaibhavi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_42531863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Pharmacology Section</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>V H, Pushpa</creatorcontrib><creatorcontrib>Shetty K, Padmaja</creatorcontrib><creatorcontrib>R N, Suresha</creatorcontrib><creatorcontrib>M K, Jayanthi</creatorcontrib><creatorcontrib>V, Ashwini</creatorcontrib><creatorcontrib>P S, Vaibhavi</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical and diagnostic research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>V H, Pushpa</au><au>Shetty K, Padmaja</au><au>R N, Suresha</au><au>M K, Jayanthi</au><au>V, Ashwini</au><au>P S, Vaibhavi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation and Comparison of Anticonvulsant Activity of Telmisartan and Olmesartan in Experimentally Induced Animal Models of Epilepsy</atitle><jtitle>Journal of clinical and diagnostic research</jtitle><date>2014-10-01</date><risdate>2014</risdate><volume>8</volume><issue>10</issue><spage>HC08</spage><epage>HC11</epage><pages>HC08-HC11</pages><issn>2249-782X</issn><eissn>0973-709X</eissn><abstract>Background : Epilepsy is one common neurological disorder requiring newer targets and newer drugs for its efficient management. In the recent days brain renin angiotensin system has gained immense importance because of its involvement in seizure regulation. Objective : To evaluate and compare antiepileptic activity of different doses olmesartan and telmisartan on MES and PTZ induced seizure models. Materials and Methods : Swiss albino mice weighing around 25-30g of either sex were divided into 6 groups: Control ( Distilled Water- 10ml/kg), Standard – Sodium valproate (40mg/kg), O1 – Olmesartan (2.5mg/kg), O2 – Olmesartan (5mg/kg), T1 - Telmisartan (5mg/kg), T2 – Telmisartan (10mg/kg). After 1hour of administration of control , test and standard drugs (orally), convulsions were induced by administering PTZ (70mg/kg – i.p.) in PTZ model. Seizure latency was the parameter recorded. In MES model, suppression of tonic hind limb extension was taken as measure of efficacy. Result : The results were analysed by one-way-ANOVA followed by Bonferroni’s multiple comparison test. In MES test, dose dependently olmesartan and telmisartan significantly reduced the duration of tonic hindlimb extension in comparison to control (p&lt;0.05). T2 – 9 + 0.89secs significantly reduced the tonic hind limb extension compared to other test groups (p&lt;0.05). The percentage inhibition of seizure was T2-44.3%, O2-28.2%, T1-17.5%, O1- 12.3% respectively. In PTZ test, dose dependently olmesartan and telmisartan produced significant increase in seizure latency (p&lt;0.05). T2 - 206.6+9.83secs significantly increased seizure latency compared to other test groups (p&lt;0.05). Percentage protection from seizure is T2-52.6%, O2- 45.13%, T1- 37.5%, O1- 38.4% respectively. Conclusion : AT1 receptor antagonist, telmisartan and olmesartan in a dose dependent manner showed increase in antiepileptic activity. Temisartan at higher dose produced significant antiepileptic activity in comparison to olmesartan.</abstract><cop>Delhi, India</cop><pub>JCDR Research and Publications (P) Limited</pub><pmid>25478368</pmid><pmid>25121000</pmid><doi>10.7860/JCDR/2014/9455.5061</doi></addata></record>
fulltext fulltext
identifier ISSN: 2249-782X
ispartof Journal of clinical and diagnostic research, 2014-10, Vol.8 (10), p.HC08-HC11
issn 2249-782X
0973-709X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4253186
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Pharmacology Section
title Evaluation and Comparison of Anticonvulsant Activity of Telmisartan and Olmesartan in Experimentally Induced Animal Models of Epilepsy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T14%3A40%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20and%20Comparison%20of%20Anticonvulsant%20Activity%20of%20Telmisartan%20and%20Olmesartan%20in%20Experimentally%20Induced%20Animal%20Models%20of%20Epilepsy&rft.jtitle=Journal%20of%20clinical%20and%20diagnostic%20research&rft.au=V%20H,%20Pushpa&rft.date=2014-10-01&rft.volume=8&rft.issue=10&rft.spage=HC08&rft.epage=HC11&rft.pages=HC08-HC11&rft.issn=2249-782X&rft.eissn=0973-709X&rft_id=info:doi/10.7860/JCDR/2014/9455.5061&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_4253186%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/25478368&rfr_iscdi=true